Small fiber neuropathy occurs as a result of damage to the small fibers of the peripheral nervous system are damaged. Small fibers in the skin carries sensory information about pain and temperature. In the organs, these small fibers regulate automatic functions such as heart rate and breathing. Small fiber neuropathy may sometimes be a sign of an underlying health condition, such as diabetes or an autoimmune disease. Most small fiber neuropathies occur in a length-dependent fashion, resulting in loss of function in a stocking distribution in the lower extremities. When the condition is more advanced, a glove-like loss in the upper extremities also may occur. In rare cases, a non–length dependent neuropathy results in symptoms involving the trunk, face, proximal limbs, or other focal areas. Pain in the feet and hands is the most common early symptom of small fiber neuropathy.
DelveInsight’s, “Small Fiber Neuropathy Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Small Fiber Neuropathy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Request for Free Sample Report: https://www.delveinsight.com/sample-request/small-fiber-neuropathy-pipeline-insight
Some of Small Fiber Neuropathy Companies are:
- Vertex Pharmaceuticals
- Biogen
- And Many Others
DelveInsight’s Small Fiber Neuropathy Report covers around 3+ products under different phases of clinical development like:
- Late-stage products (Phase III)
- Mid-stage products (Phase II and Phase I/II)
- Early-stage products (Phase I/II and Phase I) along with the details of
- Pre-clinical and Discovery stage candidates
- Discontinued & Inactive candidates
- Route of Administration
Request for Free Sample Report: https://www.delveinsight.com/sample-request/small-fiber-neuropathy-pipeline-insight
Some of Small Fiber Neuropathy Therapies:
- VX-150
- Vixotrigine (BIIB 074)
- And Many Others
Current Small Fiber Neuropathy Treatment Scenario and Small Fiber Neuropathy Emerging Therapies:
- How many companies are developing Small Fiber Neuropathy drugs?
- How many Small Fiber Neuropathy drugs are developed by each company?
- How many emerging drugs are in mid-stage, and late-stage of development for the treatment of Small Fiber Neuropathy?
- What are the key collaborations (Industry–Industry, Industry–Academia), Mergers and acquisitions, licensing activities related to the Small Fiber Neuropathy therapeutics?
- What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?
- What are the clinical studies going on for Small Fiber Neuropathy and their status?
- What are the key designations that have been granted to the emerging drugs?
Request for Free Sample Report: https://www.delveinsight.com/sample-request/small-fiber-neuropathy-pipeline-insight
Table of Contents:
Introduction
Executive Summary
Small Fiber Neuropathy: Overview
Pipeline Therapeutics
- Comparative Analysis
Therapeutic Assessment
Small Fiber Neuropathy – DelveInsight’s Analytical Perspective
In-depth Commercial Assessment
Small Fiber Neuropathy Collaboration Deals
Late Stage Products (Phase III)
- Comparative Analysis
Drug name: Company name
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
- Comparative Analysis
BIIB 074: Biogen
Drug profiles in the detailed report…..
Pre-clinical and Discovery Stage Products
- Comparative Analysis
Drug name: Company name
Drug profiles in the detailed report…..
Inactive Products
Small Fiber Neuropathy Key Companies
Small Fiber Neuropathy Key Products
Small Fiber Neuropathy- Unmet Needs
Small Fiber Neuropathy- Market Drivers and Barriers
Small Fiber Neuropathy- Future Perspectives and Conclusion
Small Fiber Neuropathy Analyst Views
Small Fiber Neuropathy Key Companies
Appendix
Request for Detailed TOC: https://www.delveinsight.com/sample-request/small-fiber-neuropathy-pipeline-insight
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/small-fiber-neuropathy-pipeline-insight